Product image
InVivoMAb anti-mouse CD172a (SIRPalpha)
BE0322
ApplicationsFlow Cytometry, ImmunoPrecipitation, Western Blot, Neutralisation/Blocking
Product group Antibodies
ReactivityMouse
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-mouse CD172a (SIRPalpha)
- Delivery Days Customer7
- ApplicationsFlow Cytometry, ImmunoPrecipitation, Western Blot, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDP84
- Concentration4-11 mg/ml
- HostRat
- IsotypeIgG1
- ReactivityMouse
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Anti-SIRPalpha antibodies as a potential new tool for cancer immunotherapy. Yanagita T et al., 2017 Jan 12, JCI InsightRead more
- Inflammation-induced proteolytic processing of the SIRPalpha cytoplasmic ITIM in neutrophils propagates a proinflammatory state. Zen K et al., 2013, Nat CommunRead more
- Lack of CD47 impairs bone cell differentiation and results in an osteopenic phenotype in vivo due to impaired signal regulatory protein alpha (SIRPalpha) signaling. Koskinen C et al., 2013 Oct 11, J Biol ChemRead more
- Expression of recipient CD47 on rat insulinoma cell xenografts prevents macrophage-mediated rejection through SIRPalpha inhibitory signaling in mice. Teraoka Y et al., 2013, PLoS OneRead more
- Osteoclast formation is strongly reduced both in vivo and in vitro in the absence of CD47/SIRPalpha-interaction. Lundberg P et al., 2007 Jan 12, Biochem Biophys Res CommunRead more
- CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis. Oldenborg PA et al., 2001 Apr 2, J Exp MedRead more